HALIFAX REGIONAL HOSPITAL
1. Target Overview & Investment Thesis
HALIFAX REGIONAL HOSPITAL is a 44-bed suburban community hospital in HALIFAX, VA with $104.6M in net patient revenue and a -16.5% operating margin. The hospital serves a payer mix of 42.2% Medicare, 1.3% Medicaid, and 56.5% commercial.
Thesis: Turnaround. Our ML models identify $7.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -16.5% to -9.1% (+736bps).
| Net Revenue HCRIS | $104.6M |
| Current EBITDA COMPUTED | $-17.2M |
| Operating Margin COMPUTED | -16.5% |
| Occupancy HCRIS | 70.2% |
| Revenue / Bed COMPUTED | $2.4M |
| Net-to-Gross HCRIS | 32.3% |
| Distress Probability ML | 41.8% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of -16.5% places it below the state median. Among 41 size-comparable peers (22-88 beds), the median margin is 5.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (22-88), prioritizing same-state peers. 41 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HALIFAX REGIONAL HOSPITAL (Target) | VA | 44 | $104.6M | -16.5% |
| LONESOME PINE HOSPITAL | VA | 56 | $175.6M | 17.2% |
| CULPEPER MEMORIAL HOSPITAL | VA | 70 | $153.9M | 9.3% |
| COMMUNITY MEMORIAL HOSPITAL | VA | 66 | $135.2M | -31.0% |
| STAFFORD HOSPITAL | VA | 61 | $127.9M | 5.7% |
| SOUTHSIDE COMMUNITY HOSPITAL | VA | 80 | $113.4M | 7.3% |
| RIVERSIDE WALTER REED | VA | 67 | $108.2M | 12.5% |
| SHORE MEMORIAL HOSPITAL | VA | 52 | $103.1M | 11.4% |
| WARREN MEMORIAL HOSPITAL | VA | 46 | $97.7M | -6.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $67K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-17.2M |
| + RCM Uplift | +$7.7M |
| Pro Forma EBITDA | $-9.5M |
| Current Margin | -16.5% |
| Pro Forma Margin | -9.1% |
| WC Released (1x) | $4.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-26.5M | $-36.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-26.5M | $-49.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-23.9M | $-32.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-23.9M | $-42.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-29.2M | $-66.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-29.2M | $-82.8M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 41 hospitals with 22-88 beds
- Same-state prioritization (n=42)
- Comp margins: P25=-12.9% / P50=5.7% / P75=14.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.